1. Medtech Insight
  2. >>Archive

Financings In Brief

InspireMD plans stock offering to raise up to $46 million for stent system. Torax gets $30 mil. for GERD treatment. BioFire Diagnostics raises $25 mil. for FilmArray platform. More financings.

Embolic protection stent system developer InspireMD Inc. seeks to raise up to $46 million through the offering of additional stock to support worldwide commercialization of its MGuard stent system with embolic protection technology, according to a Sept. 24 filing with the Securities and Exchange Commission. The firms’ CE-marked MGuard Prime coronary stent system, which is currently available overseas, consists of a cobalt-chromium stent with an ultra-thin polymer micron mesh sleeve placed over it for embolic protection. The Israeli firm, which generated 2011 sales of $6 million, plans to pursue FDA approval of the device for coronary indications and anticipates a U.S. launch in 2016. Meanwhile, the firm is also developing its MGuard stent technology for peripheral and carotid applications, and plans a version with a drug-eluting bio-absorbable mesh for coronary applications.

In addition to supporting MGuard commercialization efforts, the firm plans to use a portion of the proceeds from the stock...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Medtech Insight

J&J Bets On Robotics, Cardiovascular To Grow Medtech As Tariff Hit Eases, US Manufacturing Grows

 
• By Shubham Singh

Worldwide medtech sales totaled $8.5bn in Q2, up 6.1%. Sales grew 8% in the US and 4.1% outside the US. Cardiovascular, surgery and vision were the primary growth drivers. Acquisitions and divestitures had net positive impact of 200 basis points, largely due to the acquisition of Shockwave Medical.

Experts Call For Database Of Medical Device Labels

 
• By Elizabeth Orr

A recent JAMA column called for the US FDA to create an online database of medical device labeling, arguing that the move would increase transparency and help researchers, among other benefits. Medtech Insight discussed the idea with the paper’s lead author.

Execs On The Move: July 7–11, 2025

 
• By Medtech Insight Team

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.